510(k) Report

510(k) · Cleared

Cleared

EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A, EZF21TA, EZF24A, EZF24TA, EZS21A, EZS21TA, EZS24A and EZS24TA); OptiSite Arterial Perfusion Cannulae (OPTI16, OPTI18, OPTI20 and OPTI22); EndoReturn Arterial Cannulae (ER21B and ER23B);

K233895510(k) SpecialCleared Feb 5, 202456-day reviewClass II21 CFR 870.4210

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences · DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

Cleared on Feb 5, 2024 as substantially equivalent to K123370 (Edwards Lifesciences, LLC, 2013) and 2 other predicates after a 56-day review. Its family tree reaches back 2 generations to 1983. 1 of the 6 devices in its family, counting itself, has a Class I recall.

Decided
Feb 5, 2024
Review
56 days
Class
Class II
Product code
DWF
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K831769 (1983). 5 ancestors in all. No later device cites it as a predicate yet. 1 of the 6 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year cleared 2008: 1 other ancestor, 1 with a Class I recall11997: 1 other ancestor2004: 1 other ancestorK831769 · Various Cardiovascular Surgical Device · Research Industries Corp. · 1983 · recalledK123370 · EZ Glide Aortic Cannula, Aortic Perfusion Cannula with Duraflo Coating, Dispersion Aortic Perfusion Cannula · Edwards Lifesciences, LLC · 2013 · recalled19801990200020102020
Other ancestors, by generation 1 generation back: 2 other ancestors, 1 with a Class I recall12 generations back: 1 other ancestor K123370 · EZ Glide Aortic Cannula, Aortic Perfusion Cannula with Duraflo Coating, Dispersion Aortic Perfusion Cannula · Edwards Lifesciences, LLC · 2013 · recalledK831769 · Various Cardiovascular Surgical Device · Research Industries Corp. · 1983 · recalled0
  1. Root · 2 generations backK831769 Various Cardiovascular Surgical DeviceResearch Industries Corp. · 1983 · Recalled
  2. 1 generation backK123370 EZ Glide Aortic Cannula, Aortic Perfusion Cannula with Duraflo…Edwards Lifesciences, LLC · 2013 · Recalled
  3. This deviceK233895 EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A…Edwards Lifesciences · 2024

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K831769Various Cardiovascular Surgical DeviceResearch Industries Corp.19838
−1K123370EZ Glide Aortic Cannula, Aortic Perfusion Cannula with Duraflo Coating…Edwards Lifesciences, LLC20134
0 (this device)K233895EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A…Edwards Lifesciences2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200410
200811
FIG. 1 — Lineage of K233895, 1983–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DWF device

  1. #1 K251258 MC2™ Two-Stage Venous Cannula; MC2X™…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K123370EZ Glide Aortic Cannula, Aortic Perfusion Cannula with Duraflo Coating, Dispersion…
Summary page 6
…ted Predicate Devices Predicate # Predicate Trade Name (Primary Product Code Predicate is listed first) K123370 EZ Glide Aortic Perfusion Cannulae DWF K073559 OptiSite Arterial Perfusion…
Edwards Lifesciences, LLC20134
*K07355918 FR. Rmi Arterial Perfusion Cannula II, 20 FR. Rmi Arterial Perfusion Cannula II
Summary page 6
…(Primary Product Code Predicate is listed first) K123370 EZ Glide Aortic Perfusion Cannulae DWF K073559 OptiSite Arterial Perfusion Cannulae DWF K971291 EndoReturn Arterial Cannulae…
Edwards Lifesciences Research Medical2008Class I
*K971291Heartport Endoarterial Return Cannula
Summary page 6
…listed first) K123370 EZ Glide Aortic Perfusion Cannulae DWF K073559 OptiSite Arterial Perfusion Cannulae DWF K971291 EndoReturn Arterial Cannulae DWF Device Description Summary EZ Glide Aortic Perfusion Cannu…
Heartport, Inc.19976

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K07355918 FR. Rmi Arterial Perfusion Cannula II, 20 FR. Rmi Arterial Perfusion Cannula IIEdwards Lifesciences Research Medical · 2008 · Direct predicate · ◆ in the 2008 ancestors bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 41 years and passes through 3 companies; a new generation was cleared every 29.6 years on median.
  • 5 of the 5 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All DWF devices

DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · DWF

4in 2025

2007: 22008: 62009: 82010: 32011: 52012: 102013: 92014: 142015: 92016: 32017: 52018: 52019: 32020: 32021: 52022: 22023: 22024: 32025: 42026 (partial year): 8
2007high 14 (2014) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DWF

89in 2025

2008: 95 days median2009: 148 days median2010: 62 days median2011: 85 days median2012: 110 days median2013: 110 days median2014: 110 days median2015: 46 days median2016: 32 days median2017: 127 days median2018: 30 days median2019: 120 days median2020: 30 days median2021: 358 days median2024: 29 days median2025: 89 days median2026 (partial year): 81 days median
2007high 358 (2021) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DWF

4in 2024

2007: 252008: 252009: 212010: 262011: 132012: 372013: 14, 1 Class I2014: 62015: 3, 1 Class I2016: 32017: 2, 1 Class I2018: 102019: 22021: 32024: 42026 (partial year): 20
2007high 37 (2012) · low 0 (2020)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DWF

1,020in 2025

2007: 1212008: 1262009: 992010: 1972011: 2122012: 2332013: 2382014: 3252015: 2182016: 1442017: 1012018: 1182019: 1792020: 1422021: 1622022: 2762023: 4702024: 4012025: 1,020
2007high 1,020 (2025) · low 99 (2009)2025

MAUDE reports naming product code DWF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—25121
200869525126
200981482199
201036226197
201158513212
20121011037233
2013911014 (1)238
2014141106325
20159463 (1)218
20163323144
201751272 (1)101
201853010118
201931202179
20203300142
202153583162
20222—0276
20232—0470
20243294401
202548901,020
202688120—

What is it indicated for?

The Edwards Lifesciences arterial perfusion cannulae are indicated for arterial perfusion in the extracorporeal circuit for < 6 hours. Cannulation site selection is left to the discretion of the surgeon and may include the femoral artery or the aortic arch. The EndoReturn arterial cannula are indicated for patients undergoing cardiopulmonary bypass. They are intended to deliver oxygenated blood for cardiopulmonary bypass during surgery. The EndoReturn…

Read the full statement (135 words)

The Edwards Lifesciences arterial perfusion cannulae are indicated for arterial perfusion in the extracorporeal circuit for < 6 hours. Cannulation site selection is left to the discretion of the surgeon and may include the femoral artery or the aortic arch.

The EndoReturn arterial cannula are indicated for patients undergoing cardiopulmonary bypass. They are intended to deliver oxygenated blood for cardiopulmonary bypass during surgery.

The EndoReturn arterial cannula with hemostasis valve also allows the hemostatic introduction and removal of vascular catheters such as the EndoClamp aortic catheter.

Aortic perfusion cannulae are intended for perfusion of the aorta during short-term (≤6 hours) cardiopulmonary bypass procedures.

Aortic perfusion cannulae may be used in pediatric or adult populations based on the flow rate requirements and individual patient anatomy. Please consult labeling to determine pressure drop related to flow rates.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233895: EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A, EZF21TA, EZF24A, EZF24TA, EZS21A, EZS21TA, EZS24A and EZS24TA); OptiSite Arterial Perfusion Cannulae (OPTI16, OPTI18, OPTI20 and OPTI22); EndoReturn Arterial Cannulae (ER21B and ER23B);.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233895

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026